GS
RLYB icon

GTS Securities’s Rallybio RLYB Stock Holding History

GTS Securities’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$197K Buy
+22,016
New +$150K 0.01% 1380

Other funds holding RLYB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

GTS Securities's RLYB Position: Q1 2026 in Review

GTS Securities opened a new position in Rallybio (RLYB) in Q1 2026: 22,016 shares worth $197K. The stake represents 0.01% of the portfolio and ranks #1380 among its holdings.

38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • GTS Securities held 22,016 shares of Rallybio worth $197K as of Q1 2026.
  • Rallybio was a new GTS Securities position in Q1 2026.
  • Rallybio made up 0.01% of GTS Securities's portfolio in Q1 2026, its #1380 holding.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.